Senology apps for iPad, iPhone, and Android tablets now available, to provide anytime, anywhere access to Senology contents

Join us on  LinkedIn, Twitter, Facebook, YouTube, ResearchGate, SlideShare, Flickr, and share comments. 

Read Senology Newspaper daily

Literature Selection

• Santagata S et al.: "Taxonomy of breast cancer based on normal cell phenotype predicts outcome", J Clin Invest. 2014 Feb 3;124(2):859-70
• Petrovic N et al.: "The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion", Med Oncol. 2014 Mar;31(3):867
• Heo DS et al.: "Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients", Oncol Rep. 2014 Jan 27 [Epub ahead of print]
• Glantz SA et al.: "The surgeon general report on smoking and health 50 years later: breast cancer and the cost of increasing caution", Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):37-46
• Nishino Y et al.: "Cigarette smoking and breast cancer risk in relation to joint estrogen and progesterone receptor status: a case-control study in Japan", Springerplus. 2014 Feb 3;3:65
• Zhou Q et al.: "For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures", PLoS One. 2014 Jan 2;9(1):e83646
• Smith GL et al.: "Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation", Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):274-84
• Kiecolt-Glaser JK et al.: "Yoga's Impact on Inflammation, Mood, and Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial", J Clin Oncol. 2014 Jan 27. [Epub ahead of print]
• Lee YW et al.: "Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: A population-based study", Cancer. 2014 Feb 3. doi: 10.1002/cncr.28579. [Epub ahead of print]

Editorial

• "Prognostic significance of androgen receptor expression in breast cancer" -  Alberto Ocana Fernandez, Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain
   
  "The androgen receptor is expressed frequently in breast cancer, but its prognostic significance is unclear.  To address this issue we performed a systematic review of electronic databases to identify studies published between 1946 and July 2012, that included nineteen studies with a total of 7693 women. 60.5% of breast cancer patients expressed the androgen receptor. Estrogen receptor-positive tumors were more likely to express the androgen receptor. Expression of　this receptor were associated with improved overall survival (OS) at both 3 and 5 years. In conclusion the　expression of the androgen receptor　in women with breast cancer is associated with better　overall survival　and disease free survival irrespective of coexpression of ER. Ongoing studies are evaluating the role of targetting this receptor in different breast cancer subtypes”.
  (Commentary on: Vera-Badillo FE et al.: "Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis", J Natl Cancer Inst. 2014 Jan 1;106(1):djt319)

 Calendar of Events

• 24th Annual Interdisciplinary Breast Center Conference, March 15-19, 2014, Las Vegas, NV, USA  
• 9th European Breast Cancer Conference, March 19-21, 2014, Glasgow, Scotland
• IMPAKT Breast Cancer Conference 2014, May 8-10 2014, Brussels, Belgium

Literature Selection

• Lee IM et al.: "Physical activity and survival after cancer diagnosis in men", J Phys Act Health. 2014 Jan;11(1):85-90
• Trabert B et al.: "Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium", J Natl Cancer Inst. 2014 Feb 1;106(2):djt431
• Ma Y et al.: "High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy", Sci Transl Med. 2014 Feb 5;6(222):222ra18
• Morton DL et al.: "Final trial report of sentinel-node biopsy versus nodal observation in melanoma", N Engl J Med. 2014 Feb 13;370(7):599-609
• Yu SC et al.: "Unresectable Hepatocellular Carcinoma: Randomized Controlled Trial of Transarterial Ethanol Ablation versus Transcatheter Arterial Chemoembolization", Radiology. 2014 Feb;270(2):607-20
• Mamtani R et al.: "Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas", Diabetes Care. 2014 Feb 4. [Epub ahead of print]